Estimating the economic burden of colorectal cancer in China, 2019-2030: A population-level prevalence-based analysis.

The population-level economic burden of CRC in China in 2019 seemed noteworthy, with the direct expenditure accounting for more than half. Without effectively reducing exposure to modifiable factors and expanding screening coverage, the burden would continue increasing.